Company:  ALTIMMUNE, INC. (ALT)
Form Type:  4
Filing Date:  9/14/2018 
CIK:  0001326190 
Address:  910 CLOPPER ROAD
SUITE 201S
 
City, State, Zip:  GAITHERSBURG, Maryland 20878 
Telephone:  (240) 654-1450 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.23  
Change: 
0.04 (1.83%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$30.00M
Trade ALT now with 

© 2019  
Description of Business
Altimmune, Inc. is a clinical stage immunotherapeutics company focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Our product candidates are focused in two key areas for which we have unique proprietary approaches; i) our synthetic peptide technology for cancer and infectious disease, and ii) intranasal vaccines for infectious disease. Using these technologies, we have generated preclinical and clinical product candidates that potentially represent an entirely new approach to harnessing the immune system. In addition, we are seeking to acquire or in-license product candidates in immunotherapeutic indications that are either synergistic or complementary to our capabilities to expand our pipeline. HepTcell HepTcell is an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus ("HBV").
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES